Cefuroxime axetil (Zinnat): Discontinuation
GSK has advised that it will discontinue cefuroxime (Zinnat) tablets (Pharmacode 682810).
Discontinuation of Zinnat
Due to a significant decline in usage of this product in Aotearoa, GSK (the supplier) has advised that it will discontinue cefuroxime (Zinnat) tablets (Pharmacode 682810).
Schedule listing for Zinnat(external link)
Key dates
1 July 2023: Zinnat tab delisted from the Hospital Medicine List.
31 August 2023: Existing stock of Zinnat tab is expected to be exhausted.
1 March 2024: Zinnat tab will be de-listed from the Pharmaceutical Schedule.
Alternatives to consider
There are other funded cephalosporins.
Funded cephalosporins and cephamycins(external link)
If you have a prescription for Zinnat, there should be ample supplies of Zinnat to meet your needs.
Who to contact
If you have any questions about funding for Zinnat or other medicines, email enquiry@pharmac.govt.nz